These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 5553226

  • 1. [Our experience in antalgic therapy of peripheral arteriopathies].
    Tufano R, Portolano F, Bimonte D.
    Rass Int Clin Ter; 1971 Mar 31; 51(6):370-4. PubMed ID: 5553226
    [No Abstract] [Full Text] [Related]

  • 2. Preliminary results in the treatment of peripheral arteriopathies with a new pharmacologic substance: I-(2"pyrimidyl)4 piperonyl piperazine (ET 495).
    Royer RJ.
    Bibl Cardiol; 1969 Mar 31; 26():174-9. PubMed ID: 5402343
    [No Abstract] [Full Text] [Related]

  • 3. [Prolonged intravenous and intra-arterial administration of large doses of Raubasine in peripheral arterial diseases].
    Raso AM, Silvestrini P.
    Minerva Med; 1973 Mar 29; 64(19):961-9. PubMed ID: 4703313
    [No Abstract] [Full Text] [Related]

  • 4. [Medical therapy of obliterating arteriopathies].
    Schwarz D.
    Minerva Med; 1969 Oct 31; 60(87):4335-44. PubMed ID: 4242895
    [No Abstract] [Full Text] [Related]

  • 5. [On the therapeutic activity of hemaseril in treatment of ischemic arteriopathies and phlebopathies].
    Tattoni G, Bigazzi P, Gritta G.
    Clin Ter; 1974 Mar 15; 69(3):225-39. PubMed ID: 4846656
    [No Abstract] [Full Text] [Related]

  • 6. [A method of insulin therapy of chronic obliterating arteriopathies. Clinical results and etiopathogenetic considerations].
    Bonessa C, Cremonini L.
    Minerva Med; 1966 Jul 02; 57(44):2027-40. PubMed ID: 5942708
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Possibilities for clinical use of prostacyclin in vascular disease.
    Poredos P.
    Pflugers Arch; 2000 Jul 02; 440(5 Suppl):R137-8. PubMed ID: 11005643
    [Abstract] [Full Text] [Related]

  • 11. [Use of a new sympatholytic drug in therapy of chronic peripheral obliterating artery diseases].
    Vittori C, Taborelli G, Taborelli R.
    Minerva Cardioangiol; 1965 Sep 02; 13(9):585-91. PubMed ID: 5851172
    [No Abstract] [Full Text] [Related]

  • 12. [Clinical and instrumental observations on the hemodynamic activity of a new drug: 7-(2-(3-pyridyl-methylamino)-ethyl)-theophylline nicotinate].
    Jovino R, Renda A.
    Minerva Cardioangiol; 1971 Dec 02; 19(12):709-18. PubMed ID: 5129037
    [No Abstract] [Full Text] [Related]

  • 13. [Effect of carbogaseous baths in the treatment of chronic peripheral obliterating arteriopathies].
    Brassai Z, Horváth E, Csögör I, Ferencz L, Benedek G, Szász B.
    Rev Med Chir Soc Med Nat Iasi; 1974 Dec 02; 78(3):603-8. PubMed ID: 4453683
    [No Abstract] [Full Text] [Related]

  • 14. [Evaluation of the cardiovascular dynamic changes induced by chorionic gonadotropin in vascular diseases].
    Melloni G, Fassini G.
    Minerva Med; 1971 Mar 28; 62(25):1297-318. PubMed ID: 5552473
    [No Abstract] [Full Text] [Related]

  • 15. [Rheographic study of the activity of some vasoactive drugs on peripheral arterial circulation].
    Capitanucci P, Martinelli M, De Gregorio M.
    Minerva Cardioangiol; 1968 Nov 28; 16(11):1074-82. PubMed ID: 5707452
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Treatment of arteriopathies of limbs by xanthinol nicotinate].
    Elbaz C.
    Phlebologie; 1969 Nov 28; 22(1):105-11. PubMed ID: 5775643
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.